MedGenome is a leading provider of molecular diagnostics solutions to hospitals and clinicians, enabling personalized healthcare. Its innovative offerings in molecular diagnostics apply advanced software and bioinformatics tools to curated omics data, combined with MedGenome’s proprietary knowledge base and powerful analytics. MedGenome’s genomics bioinformatics platform is available to global pha
rmaceuticals, research and diagnostics organizations. MedGenome has pioneered Whole Genome, Whole Exome and Multi-Gene Panel disease panel based diagnostics in India. MedGenome genomic products and services will empower doctors and patients in matters of health and disease management by providing them with relevant genetic information. MedGenome has developed many single gene tests, disease panels and investigational tests covering Oncology, Pediatrics, Prenatal, Cardiology, Ophthalmology, Neurology, and other specialties. Our OncoMD Cancer Analytics Platform curates and validates genomics and proteomics data captured from leading peer reviewed scientific journals and other relevant data sources. The platform combines curated data with software bioinformatics and powerful analytics to deliver actionable information for clinical diagnosis and treatment decisions. MedGenome also partners with clients on genomic based exploratory research and drug discovery. Our ability to leverage existing longitudinal studies, design population studies from scratch and also conduct follow up studies on cohorts provides valuable benefits to our global research partners
MedGenome was incubated for 2 years as a division of SciGenom Labs, Cochin, India. It was spun off as a separate company with headquarters in Narayana Health City, Bangalore in 2013. MedGenome at Narayana Nethralaya (NN) has a co-located lab spanning over 10,000 sq.ft of lab space at Narayana Nethralaya. MedGenome has a multi faceted team spread across the country, facilitating its pan India operations.
